Fingerprint
Dive into the research topics of 'Safety, antitumor activity, and biomarker analysis in a phase I trial of the once-daily wee1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors A C'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically